Pioglitazone alleviates inflammation in diabetic mice fed a high-fat diet via inhibiting advanced glycation end-product-induced classical macrophage activation

Atherosclerosis following renal injury is ameliorated by pioglitazone and losartan via macrophage phenotype

(2015) Suguru Yamamoto et al.   ATHEROSCLEROSIS

Hyperglycemia and PPARγ Antagonistically Influence Macrophage Polarization and Infarct Healing After Ischemic Stroke

(2015) Michael Gliem et al.   STROKE

Advanced Glycation End Products Enhance Macrophages Polarization into M1 Phenotype through Activating RAGE/NF-κB Pathway

(2015) Xian Jin et al.   Biomed Research International

Pro-inflammatory monocyte-macrophage polarization imbalance in human hypercholesterolemia and atherosclerosis

(2014) Gian Paolo Fadini et al.   ATHEROSCLEROSIS

Macrophage Functions in Atherosclerosis

(2014) Iris Zeller et al.   CIRCULATION RESEARCH

Pioglitazone suppresses neuronal and muscular degeneration caused by polyglutamine-expanded androgen receptors

(2014) Madoka Iida et al.   HUMAN MOLECULAR GENETICS

The Role of Macrophage Polarization in Infectious and Inflammatory Diseases

(2014) Adam C. Labonte et al.   MOLECULES AND CELLS

The Monocyte to Macrophage Transition in the Murine Sterile Wound

(2014) Meredith J. Crane et al.   PLoS One

Molecular Mechanisms That Influence the Macrophage M1–M2 Polarization Balance

(2014) Nan Wang et al.   Frontiers in Immunology

Monocyte–macrophage polarization balance in pre-diabetic individuals

(2013) Gian Paolo Fadini et al.   ACTA DIABETOLOGICA

Supplementation with carnosine decreases plasma triglycerides and modulates atherosclerotic plaque composition in diabetic apo E−/− mice

(2013) Bronwyn E. Brown et al.   ATHEROSCLEROSIS

Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways

(2013) Dexi Zhou et al.   CELLULAR SIGNALLING

An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathy

(2013) G. P. Fadini et al.   DIABETOLOGIA

HDL Induces the Expression of the M2 Macrophage Markers Arginase 1 and Fizz-1 in a STAT6-Dependent Process

(2013) Marie Sanson et al.   PLoS One

Pioglitazone Slows Progression of Atherosclerosis in Prediabetes Independent of Changes in Cardiovascular Risk Factors

(2012) Aramesh Saremi et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuates postincisional pain by regulating macrophage polarization

(2012) Maiko Hasegawa-Moriyama et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Advanced Glycation End Products and Diabetic Cardiovascular Disease

(2012) Anand Prasad et al.   Cardiology in Review

Macrophage polarization and plasticity in health and disease

(2012) Subhra K. Biswas et al.   IMMUNOLOGIC RESEARCH

The mannose receptor

(2012) Luisa Martinez-Pomares   JOURNAL OF LEUKOCYTE BIOLOGY

Inflammation and diabetes-accelerated atherosclerosis: myeloid cell mediators

(2012) Jenny E. Kanter et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Monocyte and Macrophage Dynamics During Atherogenesis

(2011) Klaus Ley et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Antiatherogenic effect of pioglitazone on uremic apolipoprotein E knockout mice by modulation of the balance of regulatory and effector T cells

(2011) Yan Shen et al.   ATHEROSCLEROSIS

The Effects of Pioglitazone in Reducing Atherosclerosis Progression and Neointima Volume in Type 2 Diabetic Patients: Prospective Randomized Study With Volumetric Intravascular Ultrasonography Analysis

(2011) Sung Hye You et al.   Korean Circulation Journal

Pioglitazone Suppresses Inflammation In Vivo in Murine Carotid Atherosclerosis

(2010) Kiyuk Chang et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Unbalanced M1/M2 Phenotype of Peripheral Blood Monocytes in Obese Diabetic Patients: Effect of pioglitazone

(2009) N. Satoh et al.   DIABETES CARE

PPAR-γ agonist inhibits Ang II-induced activation of dendritic cells via the MAPK and NF-κB pathways

(2009) Zhu Wei-guo et al.   IMMUNOLOGY AND CELL BIOLOGY

Regulation of advanced glycation end product (AGE)-receptor (RAGE) system by PPAR-gamma agonists and its implication in cardiovascular disease

(2009) Sho-ichi Yamagishi et al.   PHARMACOLOGICAL RESEARCH

Peroxisome Proliferator-Activated Receptor-γ–Mediated Effects in the Vasculature

(2008) Sheng Zhong Duan et al.   CIRCULATION RESEARCH

Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes

(2008) Steven E. Nissen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Docosahexaenoic acid sensitizes Ramos cells to Gamma-irradiation-induced apoptosis through involvement of PPAR-γ activation and NF-κB suppression

(2008) Hamid Zand et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists

(2007) Ramya Kapadia   Frontiers in Bioscience-Landmark